IVI RMA North America Rebrands U.S. Operations as Everleap Fertility
For best results when printing this announcement, please click on link below: IVI RMA North America Rebrands U.S. Operations as Everleap Fertility Reproductive Medicine Pioneer and Leader in Fertility Research Unites 85+ Clinics and Labs, 200 Physicians and Embryologists Across Nine Brands to Guide Next Generation of Personalized Care and Innovation IVI RMA North America, a leader in fertility care and reproductive medicine, announced today that it has rebranded its U.S. operations as Everleap Fertility ( ). Built on the legacy of RMA, Boston IVF, Conceptions and other renowned U.S. fertility practices, Everleap Fertility unites more than 200 physicians and embryologists across more than 85 clinics and IVF laboratories. For over 40 years these professionals have been a driving force in shaping the field of reproductive medicine and have helped hundreds of thousands of patients build families and preserve their fertility. “We've built something remarkable across nine brands in the United States — each with deep roots in their communities, extraordinary clinical talent, and a shared commitment to patients,” said Lynn Mason, CEO of Everleap Fertility. “We have also experienced massive
S. S. operations as Everleap Fertility ( ). S.
fertility practices, Everleap Fertility unites more than 200 physicians and embryologists across more than 85 clinics and IVF laboratories. For over 40 years these professionals have been a driving force in shaping the field of reproductive medicine and have helped hundreds of thousands of patients build families and preserve their fertility. “We've built something remarkable across nine brands in the United States — each with deep roots in their communities, extraordinary clinical talent, and a shared commitment to patients,” said Lynn Mason, CEO of Everleap Fertility. S.
S. in 2027 Offering patients predictable pricing through partnerships with Gaia and PatientFi Partnerships with leading academic institutions including the University of North Carolina, Jefferson University, Harvard University and the University of Utah Revolutionizing Patient Care with Artemis and AiVA Everleap’s latest milestone along with the rebrand is the unveiling of AiVA, an AI-powered companion to Artemis, the company’s proprietary electronic medical records (EMR), workflow, and clinical intelligence platform.
Built on four decades of pioneering reproductive medicine expertise and longitudinal patient and clinical data, AiVA enables physicians to access insights from a comprehensive knowledge base, supporting evidence-based, personalized care and more informed clinical decision-making. “Everleap and our parent organization, IVI Institute, are well known for advancing the science of fertility with the latest technology,” said Dr. Thomas Molinaro, Chief Medical Officer of Everleap Fertility. S.
S. women of reproductive age have experienced infertility. To learn more about the Fertility Barometer’s findings, visit About Everleap Fertility Built on the legacy of RMA, Boston IVF, Conceptions and six other renowned North American fertility practices, Everleap Fertility brings together more than 200 physicians and embryologists across more than 65 clinics and 26 IVF laboratories. Together, we have helped hundreds of thousands of patients build families and have helped shape reproductive medicine for more than 40 years.
Everleap Fertility’s national scale and collective intelligence are focused on the next leap forward in reproductive medicine through ever-advancing standards across our clinics, ever-more personalized treatment delivered by expert local teams, and ever-better experiences for every person who comes to us for care. As a member of IVI Institute, the global leader in reproductive medicine, we draw on the unmatched knowledge of our global network to help people through every scenario and ensure patients benefit immediately from advances in our field. com) 510-409-3646